Related Experiment Video

Updated: Apr 4, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.3K

The Metabolism of Anticancer Drugs by the Liver: Current Approaches to the Drug Development Process

Mariusz Belka, Tomasz Bączek1

  • 1Medical University of Gdansk, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Al. Gen. J. Hallera 107, 80-416, Gdansk, Poland. tbaczek@gumed.edu.pl.

Current Drug Metabolism
|September 1, 2015
PubMed

Insights

Understanding how metabolic enzymes affect anticancer drug efficacy is crucial for developing new treatments. This review covers metabolic studies, analytical techniques, and computational strategies in anticancer drug development.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Drug Development

Background:

  • Metabolic enzymes significantly influence anticancer drug efficacy.
  • Understanding drug metabolism, particularly in the liver, is vital for new drug development.
  • Safe and effective chemotherapeutics require thorough metabolic studies.

Purpose of the Study:

  • To summarize current metabolic case studies in anticancer drug development.
  • To review the impact of metabolic enzymes, like cytochrome P450, on drug efficacy.
  • To discuss analytical and computational strategies for drug metabolism studies.

Main Methods:

  • Review of current literature on metabolic case studies in anticancer drug development.
  • Description of metabolic enzyme impacts, focusing on cytochrome P450.
  • Discussion of in vitro enzymatic systems and analytical techniques (LC-MS, structural elucidation).
  • Exploration of computer-aided strategies and recent advances (microdosing, IVIVC).

Main Results:

  • Metabolic enzymes, especially cytochrome P450, play a key role in anticancer drug action.
  • Various in vitro systems and analytical methods are available for studying drug metabolism.
  • Computational tools aid in decision-making during drug design.
  • Recent advancements like microdosing enhance metabolic studies.

Conclusions:

  • Metabolic studies are integral to modern anticancer drug development pipelines.
  • Integrating enzyme activity, analytical techniques, and computational strategies optimizes drug design.
  • Continued research in drug metabolism is essential for discovering safer, more effective anticancer therapies.

More Related Videos

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

10.4K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.7K

Related Concept Videos

Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
4.2K
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
6.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
337
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
118